175
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Carriage of Neisseria meningitidis Among Umrah Pilgrims: Circulating Serogroups and Antibiotic Resistance

, ORCID Icon, , , & ORCID Icon
Pages 4685-4696 | Published online: 23 Aug 2022

References

  • Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–20.
  • Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53(Pt 9):821–832. doi:10.1099/jmm.0.45529-0
  • Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51–B63. doi:10.1016/j.vaccine.2009.04.063
  • Yezli S. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: a comprehensive review. Travel Med Infect Dis. 2018;24:51–58. doi:10.1016/j.tmaid.2018.05.003
  • Badahdah AM, Rashid H, Khatami A, Booy R. Meningococcal disease burden and transmission in crowded settings and mass gatherings other than Hajj/Umrah: a systematic review. Vaccine. 2018;36(31):4593–4602. doi:10.1016/j.vaccine.2018.06.027
  • Yezli S, Yassin Y, Awam A, Attar A, Al-Jahdali E, Umrah AB. An opportunity for mass gatherings health research. Saudi Med J. 2017;38(8):868–871. doi:10.15537/smj.2017.8.20124
  • Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60–64. doi:10.1016/j.ijid.2016.04.007
  • Yezli S, Bin Saeed AA, Assiri AM, et al. Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects. Int J Infect Dis. 2016;47:71–78. doi:10.1016/j.ijid.2015.12.010
  • Wilder-Smith A, Paton NI, Barkham TM, Earnest A. Meningococcal carriage in Umrah pilgrims returning from Saudi Arabia. J Travel Med. 2003;10(3):147–149. doi:10.2310/7060.2003.35751
  • Ashgar S, El-Said H, Johargy A, et al. Prevalence of nasal carriage of Neisseria meningitidis among Umrah visitors and pilgrims during Umrah and Hajj season. Glo Adv Res J Microbiol. 2013;2:141–149.
  • Yezli S, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings: a, C, W, Y may be covered but don’t forget the B and X factors! Travel Med Infect Dis. 2017;15:5–7. doi:10.1016/j.tmaid.2017.02.001
  • Aye AMM, Bai X, Borrow R, et al. Meningococcal disease surveillance in the Asia-Pacific region (2020): the global meningococcal initiative. J Infect. 2020;81(5):698–711. doi:10.1016/j.jinf.2020.07.025
  • Willerton L, Lucidarme J, Walker A, et al. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19). PLoS One. 2021;16(11):e0260677. doi:10.1371/journal.pone.0260677
  • Vacca P, Fazio C, Neri A, Ambrosio L, Palmieri A, Stefanelli P. Neisseria meningitidis antimicrobial resistance in Italy, 2006 to 2016. Antimicrob Agents Chemother. 2018;62(9):e00207–e00218.
  • Yezli S, Wilder-Smith A, Bin Saeed AA. Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:65–70. doi:10.1016/j.ijid.2015.11.014
  • Alasmari A, Houghton J, Greenwood B, et al. Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca. Trop Med Int Health. 2021;26(4):453–461. doi:10.1111/tmi.13546
  • Wilder-Smith A, Barkham TM, Earnest A, Paton NI. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ. 2002;325(7360):365–366. doi:10.1136/bmj.325.7360.365
  • Tezer H, Gulhan B, Simge Gisi A, et al. The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey. Hum Vaccin Immunother. 2020;16(6):1268–1271. doi:10.1080/21645515.2019.1680084
  • Memish ZA, Al-Tawfiq JA, Almasri M, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: a cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine. 2017;35(18):2473–2478. doi:10.1016/j.vaccine.2017.03.027
  • McMillan M, Chandrakumar A, Wang HLR, et al. Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis. Clin Infect Dis. 2021;73(3):e609–e619. doi:10.1093/cid/ciaa1733
  • Tobaiqy M, Alhasan AH, Shams MM, et al. Assessment of preventative measures practice among Umrah Pilgrims in Saudi Arabia, 1440H-2019. Int J Environ Res Public Health. 2020;18(1):257.
  • Yezli S, Mushi A, Almuzaini Y, Balkhi B, Yassin Y, Khan A. Prevalence of diabetes and hypertension among Hajj pilgrims: a systematic review. Int J Environ Res Public Health. 2021;18(3):1155.
  • Goni MD, Naing NN, Hasan H, et al. Uptake of recommended vaccines and its associated factors among Malaysian pilgrims during Hajj and Umrah 2018. Front Public Health. 2019;7:268. doi:10.3389/fpubh.2019.00268
  • Aziz MM, Abd El-Megeed HS, Abd Ellatif MAM. Pre-travel health seeking practices of Umrah pilgrims departing from Assiut International Airport, Egypt. Travel Med Infect Dis. 2018;23:72–76. doi:10.1016/j.tmaid.2018.04.012
  • Goni MD, Naing NN, Hasan H, et al. A confirmatory factor analysis of the knowledge, attitude and practice questionnaire towards prevention of respiratory tract infections during Hajj and Umrah. BMC Public Health. 2020;20(1):1684. doi:10.1186/s12889-020-09756-5
  • Dauda Goni M, Hasan H, Naing NN, et al. Assessment of knowledge, attitude and practice towards prevention of respiratory tract infections among Hajj and Umrah pilgrims from Malaysia in 2018. Int J Environ Res Public Health. 2019;16(22):4569.
  • Edouard S, Al-Tawfiq JA, Memish ZA, Yezli S, Gautret P. Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines. Vaccine. 2018;36(48):7415–7422. doi:10.1016/j.vaccine.2018.09.017
  • Alqahtani AS, Althimiri NA, BinDhim NF. Saudi Hajj pilgrims’ preparation and uptake of health preventive measures during Hajj 2017. J Infect Public Health. 2019;12(6):772–776. doi:10.1016/j.jiph.2019.04.007
  • Miglietta A, Innocenti F, Pezzotti P, et al. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study. BMC Infect Dis. 2019;19(1):29. doi:10.1186/s12879-018-3598-3
  • Davies AL, O’Flanagan D, Salmon RL, Coleman TJ. Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection. Epidemiol Infect. 1996;117(2):259–266. doi:10.1017/S0950268800001436
  • Stuart JM, Cartwright KA, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet. 1989;2(8665):723–725. doi:10.1016/S0140-6736(89)90781-2
  • Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344(18):1378–1388. doi:10.1056/NEJM200105033441807
  • Choudhry AJ, Al-Mudaimegh KS, Turkistani AM, Al-Hamdan NA. Hajj-associated acute respiratory infection among hajjis from Riyadh. East Mediterr Health J. 2006;12(3–4):300–309.
  • Barasheed O, Almasri N, Badahdah AM, et al. Pilot randomised controlled trial to test effectiveness of facemasks in preventing influenza-like illness transmission among Australian Hajj Pilgrims in 2011. Infect Disord Drug Targets. 2014;14(2):110–116. doi:10.2174/1871526514666141021112855
  • He F, Yang HM, Li GM, et al. Neisseria meningitidis carriage and risk factors among teenagers in Suizhou city in China. Epidemiol Infect. 2020;148:e227. doi:10.1017/S0950268820002113
  • Cooper LV, Robson A, Trotter CL, et al. Risk factors for acquisition of meningococcal carriage in the African meningitis belt. Trop Med Int Health. 2019;24(4):392–400. doi:10.1111/tmi.13203
  • Hoang VT, Nguyen TT, Belhouchat K, et al. Antibiotic use for respiratory infections among Hajj pilgrims: a cohort survey and review of the literature. Travel Med Infect Dis. 2019;30:39–45. doi:10.1016/j.tmaid.2019.06.007
  • Fiebelkorn KR, Crawford SA, Jorgensen JH. Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents. Antimicrob Agents Chemother. 2005;49(2):536–540. doi:10.1128/AAC.49.2.536-540.2005
  • Alderson MR, Arkwright PD, Bai X, et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J Infect. 2021;84(3):289–296. doi:10.1016/j.jinf.2021.11.016